Dr. Jeffrey M. Bundy to Join United Imaging Board

The current North American president will transition to a seat on the board of directors starting in early 2027.

Updated on Oct. 29, 2026 in People

Bold flat-color editorial illustration depicting stark vertical geometric steel forms, symbolizing corporate governance and institutional oversight.
Dr. Jeffrey M. Bundy will transition from his role as president of United Imaging Healthcare North America to the board of directors in 2027. AI Illustration. Upload story photo >

United Imaging announced that Dr. Jeffrey M. Bundy will join its board of directors effective January 1, 2027. Dr. Bundy will vacate his current position as President of United Imaging Healthcare North America as part of the leadership transition.

Why it matters

This leadership shift marks a significant change for the firm, as Dr. Bundy has guided North American operations since the company launched in 2018. His move from executive management to the board signals a long-term strategic evolution for the regional branch.

Dr. Bundy has served in his current presidential role since 2018, the year the company launched its North American operations. His transition to the board will be finalized at the start of the next calendar year.

The players

United Imaging

This is a global healthcare technology company that specializes in medical imaging equipment and diagnostic solutions.

Dr. Jeffrey M. Bundy

He is the current President of United Imaging Healthcare North America who has served in the position since 2018.

The details

Dr. Bundy is stepping down from his day-to-day presidential responsibilities to focus on his new oversight role at the board level. The announcement confirms that this change in governance structure will take place at the start of 2027.

Timeline

  1. Dr. Bundy began his leadership role with the company in 2018.

  2. United Imaging formally announced the appointment on October 29, 2026.

  3. The board appointment becomes effective on January 1, 2027.

Market Landscape

This transition follows the standard corporate governance pattern where outgoing executive leaders move into board roles to ensure institutional continuity. It reflects a shift in internal strategy as the company seeks to maintain stability following its 2018 market entry.

While the leadership change is a significant internal event, it does not currently signal changes to medical product availability for local healthcare providers. Customers should not expect immediate shifts in service or support following the January appointment.

The takeaway

Leadership transitions in specialized medical technology firms often prioritize long-term continuity to maintain client trust. Residents and local medical facilities should look for future announcements regarding the company's new operational president.

Further reading

For more information on executive leadership changes in the region, visit the People section.

Source note: This article includes information reported by Star Local.